Kieran Ryan
Stock Analyst at Deutsche Bank
(1.64)
# 3,445
Out of 4,604 analysts
3
Total ratings
100%
Success rate
10%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kieran Ryan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Rated: Buy | $92 | $82.66 | +11.30% | 1 | Jul 31, 2026 | |
| PODD Insulet | Initiated Coverage: Buy | $190 | $133.26 | +42.58% | 1 | Jun 23, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | $16 | $19.59 | -20.88% | 1 | Jun 23, 2026 |
DexCom
Jul 31, 2026
Rated: Buy
Price Target: $92
Current: $82.66
Upside: +11.30%
Insulet
Jun 23, 2026
Initiated Coverage: Buy
Price Target: $190
Current: $133.26
Upside: +42.58%
Tandem Diabetes Care
Jun 23, 2026
Initiated Coverage: Hold
Price Target: $16
Current: $19.59
Upside: -20.88%